Number of the records: 1  

Early Detection on Pancreatic Cancer: 1H NMR Metabolomics Study of its Connection with Diabetes Mellitus.

  1. 1.
    SYSNO ASEP0520609
    Document TypeC - Proceedings Paper (int. conf.)
    R&D Document TypeThe record was not marked in the RIV
    TitleEarly Detection on Pancreatic Cancer: 1H NMR Metabolomics Study of its Connection with Diabetes Mellitus.
    Author(s) Michálková, Lenka (UCHP-M) RID, ORCID, SAI
    Horník, Štěpán (UCHP-M) ORCID, RID, SAI
    Habartová, L. (CZ)
    Sýkora, Jan (UCHP-M) RID, ORCID, SAI
    Setnička, V. (CZ)
    Article number34
    Source TitleConference Program. - Porto : SMASH NMR Conference, 2019 - ISBN N
    Pagess. 115-116
    Number of pages2 s.
    Publication formOnline - E
    ActionSmall Molecular NMR Conference 2019 (SMASH 2019)
    Event date22.09.2019 - 25.09.2019
    VEvent locationPorto
    CountryPT - Portugal
    Event typeEUR
    Languageeng - English
    CountryPT - Portugal
    Keywordsdiabetes mellitus ; nmr spectroscopy ; statistical analysis
    Subject RIVFS - Medical Facilities ; Equipment
    OECD categoryMedical engineering
    Institutional supportUCHP-M - RVO:67985858
    AnnotationIn this work, we tested the strategy for the detection of T3cDM and early PC based on NMR metabolomics. ’H NMR spectroscopy was used to detect changes in the concentration of low molecular metabolites in the blood plasma of four groups: PC patients, long-term T2DM (lasting more than 5 years), new-onset diabetic patients (lasting less than 3 years, potential T3cDM) and healthy controls. The ChenomX software was used to identify 65 metabolites across all samples. Based on the concentrations of the identified metabolites, methods of pattern recognition (primarily PCA and OPLS-DA) and statistical tests (t-test and Wilcoxon rank sum test) were used to differentiate between the studied groups. The obtained results suggested a panel of biomarkers for the detection of PC. Within the group of new-onset diabetics, our proposed OPLS- DA model, (verified by Monte Carlo cross-validation), was able to predict possible T3cDM patients at risk of developing PC. Regarding such results, the suggested model might serve as a screening method for the early detection of PC.
    WorkplaceInstitute of Chemical Process Fundamentals
    ContactEva Jirsová, jirsova@icpf.cas.cz, Tel.: 220 390 227
    Year of Publishing2020
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.